Molecular imaging of glioblastoma multiforme using anti-insulin-like growth factor-binding protein-7 single-domain antibodies

British Journal of Cancer

Volumn 103, Issue 10, 2010, Pages 1606-1616

  Iqbal, U ^a   Albaghdadi, H ^b   Luo, Y ^c   Arbabi, M ^a   Desvaux, C ^a   Veres, T ^a   Stanimirovic, D ^a,b   Abulrob, A ^a,b  

^a NATIONAL RESEARCH COUNCIL CANADA   (Canada)

^b UNIVERSITY OF OTTAWA   (Canada)

^c UNIVERSITY OF GUELPH   (Canada)

Author keywords

brain cancer; glioblastoma; insulin like growth factor binding protein 7; molecular imaging; nanoparticles; single domain antibody

Indexed keywords

FERRIC SULFATE; RECOMBINANT ANTIBODY; RECOMBINANT PROTEIN; RECOMBINANT SOMATOMEDIN BINDING PROTEIN 7 SINGLE DOMAIN ANTIBODY; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN PURIFICATION; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; DRUG TARGETING; EX VIVO STUDY; FLUORESCENCE MICROSCOPY; GLIOBLASTOMA; IN VITRO STUDY; IN VIVO STUDY; MOLECULAR IMAGING; NEUROIMAGING; NONHUMAN; PRIORITY JOURNAL; SURFACE PLASMON RESONANCE;

ANIMALS; ANTIBODIES; BRAIN; BRAIN NEOPLASMS; DNA PRIMERS; DNA, COMPLEMENTARY; GENE AMPLIFICATION; GLIOBLASTOMA; HUMANS; IMMUNOGLOBULIN G; IMMUNOHISTOCHEMISTRY; INSULIN-LIKE GROWTH FACTOR BINDING PROTEINS; MICE; MICROSCOPY, FLUORESCENCE; POLYMERASE CHAIN REACTION; TISSUE DISTRIBUTION;

EID: 78149464441     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/sj.bjc.6605937     Document Type: Article

References (39)

1. Abulrob A, Brunette E, Slinn J, Baumann E, Stanimirovic D (2007) In vivo time domain optical imaging of renal ischemia-reperfusion injury: discrimination based on fluorescence lifetime. Mol Imaging 6: 304-314
2. Abulrob A, Brunette E, Slinn J, Baumann E, Stanimirovic D (2008) Dynamic analysis of the blood-brain barrier disruption in experimental stroke using time domain in vivo fluorescence imaging. Mol Imaging 7: 248-262
3. Abulrob A, Sprong H, Van Bergenen Henegouwen P, Stanimirovic D (2005) The blood-brain barrier transmigrating single domain antibody: mechanisms of transport and antigenic epitopes in human brain endothelial cells. J Neurochem 95: 1201-1214
4. Akaogi K, Okabe Y, Sato J, Nagashima Y, Yasumitsu H, Sugahara K, Miyazaki K (1996) Specific accumulation of tumor-derived adhesion factor in tumor blood vessels and in capillary tube-like structures of cultured vascular endothelial cells. Proc Natl Acad Sci USA 93: 8384-8389
5. Arbabi Ghahroudi M, Desmyter A, Wyns L, Hamers R, Muyldermans S (1997) Selection and identification of single domain antibody fragments from camel heavy-chain antibodies. FEBS Lett 414: 521-526
6. Arbabi-Ghahroudi M, To R, Gaudette N, Hirama T, Ding W, MacKenzie R, Tanha J (2009) Aggregation-resistant VHs selected by in vitro evolution tend to have disulfide-bonded loops and acidic isoelectric points. PEDS 22: 59-66
7. Barker FG, Chang SM, Huhn SL, Davis RL, Gutin PH, McDermott MW, Wilson CB, Prados MD (1997) Age and the risk of anaplasia in magnetic resonance-non-enhancing supratentorial cerebral tumors. Cancer 80: 936-941
8. Cai W, Chen K, Mohamedali KA, Cao Q, Gambhir SS, Rosenblum MG, Chen X (2006) PET of vascular endothelial growth factor receptor expression. J Nucl Med 47: 2048-2056
9. Cairns RA, Khokha R, Hill RP (2003) Molecular mechanisms of tumor invasion and metastasis: an integrated view. Curr Mol Med 3: 659-671
10. Conrath KE, Lauwereys M, Galleni M, Matagne A, Frere JM, Kinne J, Wyns L, Muylderman S (2001) Beta-lactamase inhibitors derived from single-domain antibody fragments elicited in the camelidae. Antimicrob Agents Chemother 45: 2807-2812
11. Daumas-Duport C, Tucker ML, Kolles H, Cervera P, Beuvon F, Varlet P, Udo N, Koziak M, Chodkiewicz JP (1997a) Oligodendrogliomas. Part II: A new grading system based on morphological and imaging criteria. J Neurooncol 34: 61-78
12. Daumas-Duport C, Varlet P, Tucker ML, Beuvon F, Cervera P, Chodkiewicz JP (1997b) Oligodendrogliomas. Part I: Patterns of growth, histological diagnosis, clinical and imaging correlations: a study of 153 cases. J Neurooncol 34: 37-59
13. Doyle PJ, Arbabi-Ghahroudi M, Gaudette N, Furzer G, Savard ME, Gleddie S, McLean MD, Mackenzie CR, Hall JC (2008) Cloning, expression, and characterization of a single-domain antibody fragment with affinity for 15-acetyl-deoxynivalenol. Mol Immunol 45: 3703-3713
14. Ferrara N (2004) Vascular endothelial growth factor: basic science and clinical progress. Endocr Rev 25: 581-611
15. Goncalves M, Estieu-Gionnet K, Berthelot T, Lain G, Bayle M, Canron X, Betz N, Bikfalvi A, Deleris G (2005) Design, synthesis, and evaluation of original carriers for targeting vascular endothelial growth factor receptor interactions. Pharm Res 22: 1411-1421
16. Hamers-Casterman C, Atarhouch T, Muyldermans S, Robinson G, Hamers C, Songa EB, Bendahman N, Hamers R (1993) Naturally occurring antibodies devoid of light chains. Nature 363: 446-448
17. Holthofer H, Virtanen I, Kariniemi AL, Hormia M, Linder E, Miettinen A (1982) Ulex europaeus I lectin as a marker for vascular endothelium in human tissues. Lab Invest 47: 60-66
18. Hong S, Leroueil PR, Majoros IJ, Orr BG, Baker JR, Banaszak Holl MM (2007) The binding avidity of a nanoparticle-based multivalent targeted drug delivery platform. Chem Biol 14: 107-115
19. Iqbal U, Trojahn U, Albaghdadi H, Zhang J, O'Connor-McCourt M, Stanimirovic D, Tomanek B, Sutherland G, Abulrob A (2010) Kinetic analysis of novel mono- and multivalent VHH-fragments and their application for molecular imaging of brain tumors. Br J Pharm 160(4): 1016-1028
20. Kim HS, Nagalla SR, Oh Y, Wilson E, Roberts CT, Rosenfeld RG (1997) Identification of a family of low-affinity insulin-like growth factors binding proteins (IGFBPs): characterization of connective tissue growth factor as a member of the IGFBP superfamily. Proc Natl Acad Sci USA 94: 12981-12986
21. Lim J, Guo Y, Rostollan CL, Stanfield J, Hseih JT, Sun X, Simanek EE (2008) The role of the size and number of polyethylene glycol chains in the biodistribution and tumor localization of triazine dendrimers. Mol Pharm 5: 540-547
22. Lin X, Xie J, Chen X (2010) Protein-based tumor molecular imaging probes. Amino Acids, doi:10.1007/500726-010-0545-2
23. Moserle L, Amadori A, Indraccolo S (2009) The angiogenic switch: implications in the regulation of tumor dormancy. Curr Mol Med 9: 935-941
24. Nagakubo D, Murai T, Tanaka T, Usui T, Matsumoto M, Sekiguchi K, Miyasaka M (2003) A high endothelial venule secretory protein, mac25/ angiomodulin, intereacts with multiple high endothelial venule-asso-ciated molecules including chemokines. J Immunol 171: 553-561
25. Olson JD, Riedel E, DeAngelis LM (2000) Long term outcome of low-grade oligodendroglioma and mixed glioma. Neurology 54: 1442-1448
26. Olsson AK, Dimberg A, Kreuger J, Claesson-Welsh L (2006) VEGF receptor signalling - in control of vascular function. Nat Rev Mol Cell Biol 7: 359-371
27. Pen A, Moreno MJ, Durocher Y, Deb-Rinker P, Stanimirovic DB (2008) Glioblastoma-secreted factors induce IGFPB7 and angio-genesis by modulating Smad-2-dependent TGF-b signalling. Oncogene 27: 6834-6844
28. Pen A, Moreno MJ, Martin J, Stanimirovic DB (2007) Molecular markers of extracellular matrix remodelling in glioblastoma vessels: microarray study of laser-captured glioblastoma vessels. Glia 15: 559-572
29. Schnell O, Krebs B, Carlsen J, Miederer I, Goetz C, Goldbrunner RH, Wester HJ, Haubner R, Popperl G, Holtmannspotter M, Kretzschmar HA, Kessler H, Tonn JC, Schwaigner M, Beer AJ (2009) Imaging of integrin alpha(v)beta(3) expression in patients with malignant glioma by 18F Galacto-RGD positron emission tomography. Neuro Oncol 6: 861-870
30. 3 expression in vivo. Acc Chem Res 42: 969-980
31. St Croix B, Rago C, Velculescu V, Traverso G, Romans KE, Montgomery E, LaI A, Riggins GJ, Lengauer C, Vogelstein B, Kinzler KW (2000) Genes expressed in human tumor endothelium. Science 18: 1121-1122
32. Strupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, Belanger K, Brandes AA, Marosi C, Bogdahn U, Curshmann J, Janzer RC, Ludwin SK, Gorlia T, Allgeier A, Lacombe D, Cairncross JG, Eisenhauer E, Mirimanoff RO (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352: 987-996
33. Tassa C, Duffner JL, Lewis TA, Weissleder R, Schreiber SL, Koehler AN, Shaw SY (2010) Binding affinity and kinetic analysis of targeted small molecule-modified nanoparticles. Bioconjug Chem 21: 14-19
34. Udenfriend S, Stein S, Bohlen P, Dairman W, Leimgruber W, Weigele M (1972) Fluorescamine: a reagent for assay of amino acids, peptides, proteins, and primary amines in the picomole range. Science 178: 871-872
35. Vajkoczy P, Menger MD (2000) Vascular microenvironment in gliomas. J Neurooncol 50: 99-108
36. Van Beijnum JR, Dings RP, van der Linden E, Zwaans BM, Ramaekers FC, Mayo KH, Griffioen AW (2006) Gene expression of tumor angiogenesis dissected: specific targeting of colon cancer angiogenic vasculture. Blood 108: 2339-2348
37. Varner JA, Cheresh DA (1996) Integrins and cancer. Curr Opin Cell Biol 8: 724-730
38. Weibo C, Kai C, Khalid A, Khalid M, Cao Q, Gambhir S, Rosenblum MG, Chen X (2006) PET of vascular endothelial growth factor receptor expression. J Nucl Med 47: 2048-2056
39. Zhang J, Tanha J, Hirama T, Khieu NH, To R, Tong-Sevinc H, Stone E, Brisson JR, MacKenzie CR (2004) Pentamerization of single-domain antibodies from phage libraries: a novel strategy for the rapid generation of high-avidity antibody reagents. J Mol Biol 335: 49-56